Preface
Recent innovations in the management of hepatocellular cancer in the setting of liver transplantation: preface
Editorial
Twenty years after: from Milan criteria to a “blended” approach
Review Article
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution
Review Article
Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review
Review Article
Enlarged selection criteria for hepatocellular cancer: is the upper limit needed?
Review Article
Selection of patients with hepatocellular cancer: a difficult balancing between equity, utility, and benefit
Review Article
Hepatocellular carcinoma: when is liver transplantation oncologically futile?
Review Article
Downstaging for hepatocellular cancer: harm or benefit?
Review Article
Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation
Review Article
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease?
Review Article
Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?
Review Article
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?
Review Article
Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?
Review Article
Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer
Review Article
Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
Forward
Hepatocellualr cancer and liver transplantation: from the tower of babel towards a uniform language
Guest editor: Dr. Giovanni Battista Levi Sandri
Guest editor: Dr. Quirino Lai
Disclosure:
The series “Recent Innovations in the Management of Hepatocellular Cancer in the Setting of Liver Transplantation” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Giovanni Battista Levi Sandri, Quirino Lai served as the unpaid Guest Editors for the series.
The series “Recent Innovations in the Management of Hepatocellular Cancer in the Setting of Liver Transplantation” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Giovanni Battista Levi Sandri, Quirino Lai served as the unpaid Guest Editors for the series.